Certain APIs of low molecular weight, such as antibiotics, amino acids, vitamins, and carbohydrates, can also be produced by recombinant DNA technology. 有些低分子量的原料药,如抗生素、氨基酸、维生素和糖类也可以用重组DNA来生产。
Before recombinant DNA technology enabled pharmaceutical companies to manufacture human insulin in the1980s, pig and cow insulin were routinely given to diabetic patients. 在1980年重组DNA技术出现使得药厂制造人类胰岛素出现以前,猪及牛的胰岛素已经成为为糖尿病患者治疗常规使用的药物。
As recombinant DNA technology is consummating increasingly, genetic engineering drug is frequently researched and utilized. 随着重组DNA技术的不断完善,基因工程药物的研制和利用日益增多。
Recombinant DNA technology, transgenic technology is also a matter of fact in the molecular level to create the mosaic. 重组DNA技术、转基因技术事实上也都是在制造分子层次上的嵌合体。
In this study, recombinant DNA technology was applied for producing recombinant human BMP-4 mature peptide. 因此本研究利用基因工程生产人BMP-4成熟肽。
With the development of recombinant DNA and peptide synthesize technology, and advantage in analytical separation technology, more and more proteins and peptides, such as enzyme, activators and inhibitors, poly-and monoclonal antibodies, and various vaccines, are used as pharmaceuticals in clinic. 随着重组DNA和多肽合成技术的发展,更加之分析分离技术的提高,越来越多的蛋白质和多肽,象酶、活性因子、抑制因子、多克隆与单克隆抗体、疫苗,被作为药物应用于临床。
The parents of 22 strong heterotic combinations, 'in-which Yiyuan 2, a wheat-rye recombinant was used as male parent, Were tested and analyzed by random amplified polymorphic DNA ( RAPD) markers technology. 利用RAPD技术对小麦(黑麦)异源重组系异源2号组配的22个强优势杂交组合的亲本进行了遗传差异检测分析。
Prophylactic vaccines based on the use of virus-like particles ( VLPs) obtained from auto-assembly of L1 or L1 and L2 proteins produced by recombinant DNA technology are under phase I/ II clinical trials for HPV6/ 11 associated with condylomas. 通过DNA重组技术,基于HPV6/11型L1或L1和L2蛋白自我组装成病毒样颗粒的研究已经进入了I/II期临床实验。
Nesiritide is a synthetic form of brain natriuretic peptide using recombinant DNA technology. 奈西立肽是利用重组DNA技术得到的合成型人类脑利钠肽。
DNA is the most important genetic material. So the method and technique of DNA extracting is the basic method for biochemistry, molecular biology and recombinant DNA technology. DNA是最重要的遗传物质,因此,DNA的提取方法和技术是生物化学及分子生物学最基本的技术,也是生物工程最常用的技术。
Method: Adopting the recombinant DNA technology, the prokaryotic expression plasmids of one normal recombinant and tree single-residue variants of bovine prion protein were constructed. 【方法】应用DNA重组技术,正确地构建牛朊蛋白基因的1个正常重组朊蛋白和3个单氨基酸变异体的原核表达载体,经转化E。
The successful cloning of an opioid receptor gene family has made it possible to use recombinant DNA technology at the receptor level. 阿片受体克隆成功打开了将重组DNA技术运用到受体水平的通路。
Application of recombinant DNA technology in entomology 重组DNA技术在昆虫学中的应用
Although the traditional amino acid producing methods such as chemical synthesis and isolation from natural sources are still utilized, the most significant trend in amino acid production technique is the swift and violent development of multiple method and biological synthesis, especially the application of recombinant DNA technology. 生物资源提取、化学合成、生物合成和综合法是生产氨基酸的4种技术,目前的发展趋势为生物合成和综合法,特别是将现代生物工程技术应用于氨基酸生产。
This paper introduced the expression of BMP in Pichia Pastoris using recombinant DNA technology, determined the phenotype of X-33/ pPICZ α A-BMP, optimized the growth conditions and expression conditions. 文章介绍了利用基因工程技术在酵母菌中表达BMP的方法,对构建的Pichiapastoris酵母工程菌株X-33/pPICZαA-BMP进行了发酵表达,确定了菌株的表型、高密度生长及表达条件。
Methods: An artificial egf gene was constructed with recombinant DNA technology and inserted into pQE-40 to get a expression plasmid pQE-EGF, in which egf was fused with 6 × His tag. Plasmid pQE-EGF was transformed into E. 方法:用DNA重组技术构建EGF基因并插入表达载体pQE-40,与载体上的6×His标签融合,获得的表达质粒pQE-EGF转化E。
Construction of an Amylolytic and Ethanol-producing Yeast Strain by Recombinant DNA Technology 用基因重组技术构建可降解淀粉和产生酒精的酵母工程菌
Recombinant chymosin represents one of the first successful applications of recombinant DNA technology in the food industry. 重组凝乳酶是重组DNA技术在食品工业中的首次成功应用。
Sensitive assays require a highly purified enzyme with a high turnover number, and a low detection limit for the reaction product. Diagnostic enzymes produced by recombinant DNA technology, which increased yield and quality of enzyme and simplified preparing process, improved the development of EIA greatly. 利用基因工程生产诊断用酶,使酶的纯度大大提高,产量及质量均较自然来源酶好,简化了制备程序,大大促进了酶免疫分析技术的发展。
Although we are now able to produce pharmacological peptides by recombinant DNA technology, yet we fail to produce amidated peptides in the same way because bacteria lack the a-amidase. 尽管我们能够通过重组DNA技术利用细菌生产具有药理活性的蛋白质,然而这种技术却不能用于生产酰胺化多肽,因为细菌中没有α-酰胺化酶。
This highly interdisciplinary field is closely associated with both the physical and chemical properties of organic and inorganic nanoparticles, as well as to the various aspects of molecular cloning recombinant DNA and protein technology, and immune-ology. 这种新颖的交叉跨度很高的化学学科与有机/无机纳米粒子的物理化学性质,以及分子克隆,DNA重组,蛋白质技术和免疫学有着非常紧密的联系。
The advent of recombinant DNA technology has provided efficient and cost-effective alternate sources for many therapeutic proteins. 重组DNA技术为许多治疗性蛋白的生产提供了一种有效的替代方法。
Recombinant protein refers to the use of recombinant DNA techniques in the production of the protein, whose species construct to fermentation, purification technology research development and industrialization of the recombinant protein is the important research content. 重组蛋白质是指利用DNA重组技术生产的蛋白质,重组蛋白的菌种构建至发酵、纯化的工艺研究是重组蛋白研发和产业化的重要研究内容。
However, phage-resistant starter cultures were traditionally obtained by recombinant DNA technology or conjugal transfer of plasmids confering phage resistance, which holded health potential dangers. 然而,噬菌体抗性菌株通常是通过DNA重组或携带噬菌体抗性基因的质粒的转移获得的,因而赋予所得菌株潜在的安全隐患。
Biochip technology is a great breakthrough of life science after recombinant DNA technology and polymerase chain reaction. 生物芯片技术是继基因工程(重组DNA技术)、聚合酶链式反应(PCR)之后在分子生物学领域中的又一重大突破。
Therapeutic recombinant proteins are produced by the recombinant DNA technology. 重组药用蛋白质是指利用DNA重组技术生产的蛋白质。
With the development of recombinant DNA technology and expression system, quantity of known protein increases. 随着重组DNA技术的发展和表达体系的完善,已知的蛋白质数目有了很大增长。